Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2020-2025
According to this study, over the next five years the 10-Valent Pneumococcal Polysaccharide Vaccine market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in 10-Valent Pneumococcal Polysaccharide Vaccine business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of 10-Valent Pneumococcal Polysaccharide Vaccine market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the 10-Valent Pneumococcal Polysaccharide Vaccine, covering the supply chain analysis, impact assessment to the 10-Valent Pneumococcal Polysaccharide Vaccine market size growth rate in several scenarios, and the measures to be undertaken by 10-Valent Pneumococcal Polysaccharide Vaccine companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Single Dose Vial
Pre-filled Syringe
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Clinic
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
GSK
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global 10-Valent Pneumococcal Polysaccharide Vaccine consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of 10-Valent Pneumococcal Polysaccharide Vaccine market by identifying its various subsegments.
Focuses on the key global 10-Valent Pneumococcal Polysaccharide Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the 10-Valent Pneumococcal Polysaccharide Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of 10-Valent Pneumococcal Polysaccharide Vaccine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Consumption 2015-2025
2.1.2 10-Valent Pneumococcal Polysaccharide Vaccine Consumption CAGR by Region
2.2 10-Valent Pneumococcal Polysaccharide Vaccine Segment by Type
2.2.1 Single Dose Vial
2.2.2 Pre-filled Syringe
2.3 10-Valent Pneumococcal Polysaccharide Vaccine Consumption by Type
2.3.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Type (2015-2020)
2.3.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Type (2015-2020)
2.3.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Type (2015-2020)
2.4 10-Valent Pneumococcal Polysaccharide Vaccine Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 10-Valent Pneumococcal Polysaccharide Vaccine Consumption by Application
2.5.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Type (2015-2020)
2.5.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Value and Market Share by Type (2015-2020)
2.5.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Type (2015-2020)
3 Global 10-Valent Pneumococcal Polysaccharide Vaccine by Company
3.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company
3.1.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Company (2018-2020)
3.1.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (2018-2020)
3.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company
3.2.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Company (2018-2020)
3.2.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company (2018-2020)
3.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Company
3.4 Global 10-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players 10-Valent Pneumococcal Polysaccharide Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 10-Valent Pneumococcal Polysaccharide Vaccine by Regions
4.1 10-Valent Pneumococcal Polysaccharide Vaccine by Regions
4.2 Americas 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth
4.3 APAC 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth
4.4 Europe 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth
4.5 Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth
5 Americas
5.1 Americas 10-Valent Pneumococcal Polysaccharide Vaccine Consumption by Countries
5.1.1 Americas 10-Valent Pneumococcal Polysaccharide Vaccine Consumption by Countries (2015-2020)
5.1.2 Americas 10-Valent Pneumococcal Polysaccharide Vaccine Value by Countries (2015-2020)
5.2 Americas 10-Valent Pneumococcal Polysaccharide Vaccine Consumption by Type
5.3 Americas 10-Valent Pneumococcal Polysaccharide Vaccine Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC 10-Valent Pneumococcal Polysaccharide Vaccine Consumption by Regions
6.1.1 APAC 10-Valent Pneumococcal Polysaccharide Vaccine Consumption by Regions (2015-2020)
6.1.2 APAC 10-Valent Pneumococcal Polysaccharide Vaccine Value by Regions (2015-2020)
6.2 APAC 10-Valent Pneumococcal Polysaccharide Vaccine Consumption by Type
6.3 APAC 10-Valent Pneumococcal Polysaccharide Vaccine Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe 10-Valent Pneumococcal Polysaccharide Vaccine by Countries
7.1.1 Europe 10-Valent Pneumococcal Polysaccharide Vaccine Consumption by Countries (2015-2020)
7.1.2 Europe 10-Valent Pneumococcal Polysaccharide Vaccine Value by Countries (2015-2020)
7.2 Europe 10-Valent Pneumococcal Polysaccharide Vaccine Consumption by Type
7.3 Europe 10-Valent Pneumococcal Polysaccharide Vaccine Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine by Countries
8.1.1 Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Value by Countries (2015-2020)
8.2 Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Consumption by Type
8.3 Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 10-Valent Pneumococcal Polysaccharide Vaccine Distributors
10.3 10-Valent Pneumococcal Polysaccharide Vaccine Customer
11 Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Forecast
11.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2021-2025)
11.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Forecast by Regions
11.2.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Forecast by Regions (2021-2025)
11.2.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global 10-Valent Pneumococcal Polysaccharide Vaccine Forecast by Type
11.8 Global 10-Valent Pneumococcal Polysaccharide Vaccine Forecast by Application
12 Key Players Analysis
12.1 GSK
12.1.1 Company Information
12.1.2 10-Valent Pneumococcal Polysaccharide Vaccine Product Offered
12.1.3 GSK 10-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 GSK Latest Developments
...
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. 10-Valent Pneumococcal Polysaccharide Vaccine Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Single Dose Vial
Table 5. Major Players of Pre-filled Syringe
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Type (2015-2020)
Table 8. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2015-2020) ($ million)
Table 9. Global 10-Valent Pneumococcal Polysaccharide Vaccine Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Application (2015-2020)
Table 13. Global 10-Valent Pneumococcal Polysaccharide Vaccine Value by Application (2015-2020)
Table 14. Global 10-Valent Pneumococcal Polysaccharide Vaccine Value Market Share by Application (2015-2020)
Table 15. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Application (2015-2020)
Table 16. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Company (2017-2019) (K Units)
Table 17. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (2017-2019)
Table 18. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Company (2017-2019) ($ Millions)
Table 19. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company (2017-2019)
Table 20. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Company (2017-2019)
Table 21. Global 10-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players 10-Valent Pneumococcal Polysaccharide Vaccine Products Offered
Table 23. 10-Valent Pneumococcal Polysaccharide Vaccine Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global 10-Valent Pneumococcal Polysaccharide Vaccine Consumption by Regions 2015-2020 (K Units)
Table 25. Global 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Regions 2015-2020
Table 26. Global 10-Valent Pneumococcal Polysaccharide Vaccine Value by Regions 2015-2020 ($ Millions)
Table 27. Global 10-Valent Pneumococcal Polysaccharide Vaccine Value Market Share by Regions 2015-2020
Table 28. Americas 10-Valent Pneumococcal Polysaccharide Vaccine Consumption by Countries (2015-2020) (K Units)
Table 29. Americas 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Countries (2015-2020)
Table 30. Americas 10-Valent Pneumococcal Polysaccharide Vaccine Value by Countries (2015-2020) ($ Millions)
Table 31. Americas 10-Valent Pneumococcal Polysaccharide Vaccine Value Market Share by Countries (2015-2020)
Table 32. Americas 10-Valent Pneumococcal Polysaccharide Vaccine Consumption by Type (2015-2020) (K Units)
Table 33. Americas 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Type (2015-2020)
Table 34. Americas 10-Valent Pneumococcal Polysaccharide Vaccine Consumption by Application (2015-2020) (K Units)
Table 35. Americas 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Application (2015-2020)
Table 36. APAC 10-Valent Pneumococcal Polysaccharide Vaccine Consumption by Regions (2015-2020) (K Units)
Table 37. APAC 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Regions (2015-2020)
Table 38. APAC 10-Valent Pneumococcal Polysaccharide Vaccine Value by Regions (2015-2020) ($ Millions)
Table 39. APAC 10-Valent Pneumococcal Polysaccharide Vaccine Value Market Share by Regions (2015-2020)
Table 40. APAC 10-Valent Pneumococcal Polysaccharide Vaccine Consumption by Type (2015-2020) (K Units)
Table 41. APAC 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Type (2015-2020)
Table 42. APAC 10-Valent Pneumococcal Polysaccharide Vaccine Consumption by Application (2015-2020) (K Units)
Table 43. APAC 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Application (2015-2020)
Table 44. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Consumption by Countries (2015-2020) (K Units)
Table 45. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Countries (2015-2020)
Table 46. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Value by Countries (2015-2020) ($ Millions)
Table 47. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Value Market Share by Countries (2015-2020)
Table 48. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Consumption by Type (2015-2020) (K Units)
Table 49. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Type (2015-2020)
Table 50. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Consumption by Application (2015-2020) (K Units)
Table 51. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Consumption by Countries (2015-2020) (K Units)
Table 53. Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Consumption by Type (2015-2020) (K Units)
Table 57. Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Consumption by Application (2015-2020) (K Units)
Table 59. Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Application (2015-2020)
Table 60. 10-Valent Pneumococcal Polysaccharide Vaccine Distributors List
Table 61. 10-Valent Pneumococcal Polysaccharide Vaccine Customer List
Table 62. Global 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast by Countries (2021-2025) (K Units)
Table 63. Global 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Forecast by Regions
Table 64. Global 10-Valent Pneumococcal Polysaccharide Vaccine Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global 10-Valent Pneumococcal Polysaccharide Vaccine Value Market Share Forecast by Regions
Table 66. Global 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast by Type (2021-2025) (K Units)
Table 67. Global 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global 10-Valent Pneumococcal Polysaccharide Vaccine Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global 10-Valent Pneumococcal Polysaccharide Vaccine Value Market Share Forecast by Type (2021-2025)
Table 70. Global 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast by Application (2021-2025) (K Units)
Table 71. Global 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global 10-Valent Pneumococcal Polysaccharide Vaccine Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global 10-Valent Pneumococcal Polysaccharide Vaccine Value Market Share Forecast by Application (2021-2025)
Table 74. GSK Product Offered
Table 75. GSK 10-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 76. GSK Main Business
Table 77. GSK Latest Developments
Table 78. GSK Basic Information, Company Total Revenue (in $ million), 10-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of 10-Valent Pneumococcal Polysaccharide Vaccine
Figure 2. 10-Valent Pneumococcal Polysaccharide Vaccine Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global 10-Valent Pneumococcal Polysaccharide Vaccine Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Single Dose Vial
Figure 7. Product Picture of Pre-filled Syringe
Figure 8. Global 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Type (2015-2020)
Figure 9. Global 10-Valent Pneumococcal Polysaccharide Vaccine Value Market Share by Type (2015-2020)
Figure 10. 10-Valent Pneumococcal Polysaccharide Vaccine Consumed in Hospital
Figure 11. Global 10-Valent Pneumococcal Polysaccharide Vaccine Market: Hospital (2015-2020) (K Units)
Figure 12. Global 10-Valent Pneumococcal Polysaccharide Vaccine Market: Hospital (2015-2020) ($ Millions)
Figure 13. 10-Valent Pneumococcal Polysaccharide Vaccine Consumed in Clinic
Figure 14. Global 10-Valent Pneumococcal Polysaccharide Vaccine Market: Clinic (2015-2020) (K Units)
Figure 15. Global 10-Valent Pneumococcal Polysaccharide Vaccine Market: Clinic (2015-2020) ($ Millions)
Figure 16. Global 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Application (2015-2020)
Figure 17. Global 10-Valent Pneumococcal Polysaccharide Vaccine Value Market Share by Application (2015-2020)
Figure 18. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company in 2017
Figure 19. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company in 2019
Figure 20. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company in 2017
Figure 21. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company in 2019
Figure 22. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Company in 2019
Figure 23. Global 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Regions 2015-2020
Figure 24. Global 10-Valent Pneumococcal Polysaccharide Vaccine Value Market Share by Regions 2015-2020
Figure 25. Americas 10-Valent Pneumococcal Polysaccharide Vaccine Consumption 2015-2020 (K Units)
Figure 26. Americas 10-Valent Pneumococcal Polysaccharide Vaccine Value 2015-2020 ($ Millions)
Figure 27. APAC 10-Valent Pneumococcal Polysaccharide Vaccine Consumption 2015-2020 (K Units)
Figure 28. APAC 10-Valent Pneumococcal Polysaccharide Vaccine Value 2015-2020 ($ Millions)
Figure 29. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Consumption 2015-2020 (K Units)
Figure 30. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Value 2015-2020 ($ Millions)
Figure 31. Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Consumption 2015-2020 (K Units)
Figure 32. Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Value 2015-2020 ($ Millions)
Figure 33. Americas 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Countries in 2019
Figure 34. Americas 10-Valent Pneumococcal Polysaccharide Vaccine Value Market Share by Countries in 2019
Figure 35. Americas 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Type in 2019
Figure 36. Americas 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Application in 2019
Figure 37. United States 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2015-2020 (K Units)
Figure 38. United States 10-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2015-2020 ($ Millions)
Figure 39. Canada 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2015-2020 (K Units)
Figure 40. Canada 10-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2015-2020 ($ Millions)
Figure 41. Mexico 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2015-2020 (K Units)
Figure 42. Mexico 10-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2015-2020 ($ Millions)
Figure 43. APAC 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Countries in 2019
Figure 44. APAC 10-Valent Pneumococcal Polysaccharide Vaccine Value Market Share by Regions in 2019
Figure 45. APAC 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Type in 2019
Figure 46. APAC 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Application in 2019
Figure 47. China 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2015-2020 (K Units)
Figure 48. China 10-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2015-2020 ($ Millions)
Figure 49. Japan 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2015-2020 (K Units)
Figure 50. Japan 10-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2015-2020 ($ Millions)
Figure 51. Korea 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2015-2020 (K Units)
Figure 52. Korea 10-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2015-2020 ($ Millions)
Figure 53. Southeast Asia 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2015-2020 (K Units)
Figure 54. Southeast Asia 10-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2015-2020 ($ Millions)
Figure 55. India 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2015-2020 (K Units)
Figure 56. India 10-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2015-2020 ($ Millions)
Figure 57. Australia 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2015-2020 (K Units)
Figure 58. Australia 10-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2015-2020 ($ Millions)
Figure 59. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Countries in 2019
Figure 60. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Value Market Share by Countries in 2019
Figure 61. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Type in 2019
Figure 62. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Application in 2019
Figure 63. Germany 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2015-2020 (K Units)
Figure 64. Germany 10-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2015-2020 ($ Millions)
Figure 65. France 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2015-2020 (K Units)
Figure 66. France 10-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2015-2020 ($ Millions)
Figure 67. UK 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2015-2020 (K Units)
Figure 68. UK 10-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2015-2020 ($ Millions)
Figure 69. Italy 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2015-2020 (K Units)
Figure 70. Italy 10-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2015-2020 ($ Millions)
Figure 71. Russia 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2015-2020 (K Units)
Figure 72. Russia 10-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2015-2020 ($ Millions)
Figure 73. Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Countries in 2019
Figure 74. Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Value Market Share by Countries in 2019
Figure 75. Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Type in 2019
Figure 76. Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Application in 2019
Figure 77. Egypt 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2015-2020 (K Units)
Figure 78. Egypt 10-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2015-2020 ($ Millions)
Figure 79. South Africa 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2015-2020 (K Units)
Figure 80. South Africa 10-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2015-2020 ($ Millions)
Figure 81. Israel 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2015-2020 (K Units)
Figure 82. Israel 10-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2015-2020 ($ Millions)
Figure 83. Turkey 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2015-2020 (K Units)
Figure 84. Turkey 10-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2015-2020 ($ Millions)
Figure 85. GCC Countries 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth 2015-2020 (K Units)
Figure 86. GCC Countries 10-Valent Pneumococcal Polysaccharide Vaccine Value Growth 2015-2020 ($ Millions)
Figure 87. Global 10-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 88. Global 10-Valent Pneumococcal Polysaccharide Vaccine Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 89. Americas 10-Valent Pneumococcal Polysaccharide Vaccine Consumption 2021-2025 (K Units)
Figure 90. Americas 10-Valent Pneumococcal Polysaccharide Vaccine Value 2021-2025 ($ Millions)
Figure 91. APAC 10-Valent Pneumococcal Polysaccharide Vaccine Consumption 2021-2025 (K Units)
Figure 92. APAC 10-Valent Pneumococcal Polysaccharide Vaccine Value 2021-2025 ($ Millions)
Figure 93. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Consumption 2021-2025 (K Units)
Figure 94. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Value 2021-2025 ($ Millions)
Figure 95. Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Consumption 2021-2025 (K Units)
Figure 96. Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Value 2021-2025 ($ Millions)
Figure 97. United States 10-Valent Pneumococcal Polysaccharide Vaccine Consumption 2021-2025 (K Units)
Figure 98. United States 10-Valent Pneumococcal Polysaccharide Vaccine Value 2021-2025 ($ Millions)
Figure 99. Canada 10-Valent Pneumococcal Polysaccharide Vaccine Consumption 2021-2025 (K Units)
Figure 100. Canada 10-Valent Pneumococcal Polysaccharide Vaccine Value 2021-2025 ($ Millions)
Figure 101. Mexico 10-Valent Pneumococcal Polysaccharide Vaccine Consumption 2021-2025 (K Units)
Figure 102. Mexico 10-Valent Pneumococcal Polysaccharide Vaccine Value 2021-2025 ($ Millions)
Figure 103. Brazil 10-Valent Pneumococcal Polysaccharide Vaccine Consumption 2021-2025 (K Units)
Figure 104. Brazil 10-Valent Pneumococcal Polysaccharide Vaccine Value 2021-2025 ($ Millions)
Figure 105. China 10-Valent Pneumococcal Polysaccharide Vaccine Consumption 2021-2025 (K Units)
Figure 106. China 10-Valent Pneumococcal Polysaccharide Vaccine Value 2021-2025 ($ Millions)
Figure 107. Japan 10-Valent Pneumococcal Polysaccharide Vaccine Consumption 2021-2025 (K Units)
Figure 108. Japan 10-Valent Pneumococcal Polysaccharide Vaccine Value 2021-2025 ($ Millions)
Figure 109. Korea 10-Valent Pneumococcal Polysaccharide Vaccine Consumption 2021-2025 (K Units)
Figure 110. Korea 10-Valent Pneumococcal Polysaccharide Vaccine Value 2021-2025 ($ Millions)
Figure 111. Southeast Asia 10-Valent Pneumococcal Polysaccharide Vaccine Consumption 2021-2025 (K Units)
Figure 112. Southeast Asia 10-Valent Pneumococcal Polysaccharide Vaccine Value 2021-2025 ($ Millions)
Figure 113. India 10-Valent Pneumococcal Polysaccharide Vaccine Consumption 2021-2025 (K Units)
Figure 114. India 10-Valent Pneumococcal Polysaccharide Vaccine Value 2021-2025 ($ Millions)
Figure 115. Australia 10-Valent Pneumococcal Polysaccharide Vaccine Consumption 2021-2025 (K Units)
Figure 116. Australia 10-Valent Pneumococcal Polysaccharide Vaccine Value 2021-2025 ($ Millions)
Figure 117. Germany 10-Valent Pneumococcal Polysaccharide Vaccine Consumption 2021-2025 (K Units)
Figure 118. Germany 10-Valent Pneumococcal Polysaccharide Vaccine Value 2021-2025 ($ Millions)
Figure 119. France 10-Valent Pneumococcal Polysaccharide Vaccine Consumption 2021-2025 (K Units)
Figure 120. France 10-Valent Pneumococcal Polysaccharide Vaccine Value 2021-2025 ($ Millions)
Figure 121. UK 10-Valent Pneumococcal Polysaccharide Vaccine Consumption 2021-2025 (K Units)
Figure 122. UK 10-Valent Pneumococcal Polysaccharide Vaccine Value 2021-2025 ($ Millions)
Figure 123. Italy 10-Valent Pneumococcal Polysaccharide Vaccine Consumption 2021-2025 (K Units)
Figure 124. Italy 10-Valent Pneumococcal Polysaccharide Vaccine Value 2021-2025 ($ Millions)
Figure 125. Russia 10-Valent Pneumococcal Polysaccharide Vaccine Consumption 2021-2025 (K Units)
Figure 126. Russia 10-Valent Pneumococcal Polysaccharide Vaccine Value 2021-2025 ($ Millions)
Figure 127. Spain 10-Valent Pneumococcal Polysaccharide Vaccine Consumption 2021-2025 (K Units)
Figure 128. Spain 10-Valent Pneumococcal Polysaccharide Vaccine Value 2021-2025 ($ Millions)
Figure 129. Egypt 10-Valent Pneumococcal Polysaccharide Vaccine Consumption 2021-2025 (K Units)
Figure 130. Egypt 10-Valent Pneumococcal Polysaccharide Vaccine Value 2021-2025 ($ Millions)
Figure 131. South Africa 10-Valent Pneumococcal Polysaccharide Vaccine Consumption 2021-2025 (K Units)
Figure 132. South Africa 10-Valent Pneumococcal Polysaccharide Vaccine Value 2021-2025 ($ Millions)
Figure 133. Israel 10-Valent Pneumococcal Polysaccharide Vaccine Consumption 2021-2025 (K Units)
Figure 134. Israel 10-Valent Pneumococcal Polysaccharide Vaccine Value 2021-2025 ($ Millions)
Figure 135. Turkey 10-Valent Pneumococcal Polysaccharide Vaccine Consumption 2021-2025 (K Units)
Figure 136. Turkey 10-Valent Pneumococcal Polysaccharide Vaccine Value 2021-2025 ($ Millions)
Figure 137. GCC Countries 10-Valent Pneumococcal Polysaccharide Vaccine Consumption 2021-2025 (K Units)
Figure 138. GCC Countries 10-Valent Pneumococcal Polysaccharide Vaccine Value 2021-2025 ($ Millions)
Figure 139. GSK 10-Valent Pneumococcal Polysaccharide Vaccine Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets